CA2141428A1 - Methode d'immunoselection positive de cellules souches - Google Patents

Methode d'immunoselection positive de cellules souches

Info

Publication number
CA2141428A1
CA2141428A1 CA002141428A CA2141428A CA2141428A1 CA 2141428 A1 CA2141428 A1 CA 2141428A1 CA 002141428 A CA002141428 A CA 002141428A CA 2141428 A CA2141428 A CA 2141428A CA 2141428 A1 CA2141428 A1 CA 2141428A1
Authority
CA
Canada
Prior art keywords
cells
thc
antibody
hapten
support
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002141428A
Other languages
English (en)
Inventor
Steven Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2141428A1 publication Critical patent/CA2141428A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002141428A 1992-07-28 1993-07-27 Methode d'immunoselection positive de cellules souches Abandoned CA2141428A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92104992A 1992-07-28 1992-07-28
US07/921,049 1992-07-28

Publications (1)

Publication Number Publication Date
CA2141428A1 true CA2141428A1 (fr) 1994-02-03

Family

ID=25444844

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002141428A Abandoned CA2141428A1 (fr) 1992-07-28 1993-07-27 Methode d'immunoselection positive de cellules souches

Country Status (4)

Country Link
EP (1) EP0652703A4 (fr)
AU (1) AU678179B2 (fr)
CA (1) CA2141428A1 (fr)
WO (1) WO1994002016A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646001A (en) * 1991-03-25 1997-07-08 Immunivest Corporation Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
WO1994007138A1 (fr) 1992-09-14 1994-03-31 Fodstad Oystein Detection de cellules cibles specifiques dans une population de cellules specialisees ou mixtes et solutions contenant des populations de cellules mixtes
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
US5968753A (en) * 1994-06-14 1999-10-19 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
US5985660A (en) * 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
US5972627A (en) * 1994-06-15 1999-10-26 Systemix, Inc. Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
WO1996023872A1 (fr) * 1995-02-02 1996-08-08 Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis Enrichissement de cellules souches hematopoietiques provenant du sang ou de la moelle osseuse
WO1996031776A1 (fr) * 1995-04-06 1996-10-10 Miltenyi Bioteh, Inc. Separation cellulaire multi-parametre faisant appel a des particules magnetiques colloïdales liberables
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
NO961031D0 (no) * 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Fremgangsmåte til å drepe uönskede målceller
US5928638A (en) * 1996-06-17 1999-07-27 Systemix, Inc. Methods for gene transfer
US6096540A (en) * 1996-09-30 2000-08-01 Becton Dickinson And Company Differentiation of granulocytic and monocytic progenitor cells
WO1998020043A1 (fr) 1996-11-08 1998-05-14 Morphogenesis, Inc. Materiaux et procedes pour la purification de cellules
EP0972183A4 (fr) * 1997-04-04 2006-12-06 Biosite Inc Methodes mettant en oeuvre des particules magnetiques pour concentrer des ligands
JP2004501110A (ja) * 2000-05-23 2004-01-15 ネクセル　セラピューティックス　インコーポレイティド 細胞選択用試薬および使用方法
ITUD20020092A1 (it) * 2002-04-30 2002-07-30 Univ Degli Studi Udine Metodo per l'identificazione e l'isolamento di cellule staminali di un tessuto umano
DE10256042B4 (de) * 2002-11-30 2006-06-08 Universität Potsdam Verfahren zur Selektion von Zellen, die spezifisch bindende Moleküle produzieren
EP2039348A1 (fr) * 2007-09-21 2009-03-25 Jürgen Schliefelbein Préparation cosmétique et procédé pour obtenir une préparation de cellule souche somatique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
EP0260280B2 (fr) * 1986-01-30 1995-09-20 Fred Hutchinson Cancer Research Center Procede de selection immunologique
US4778751A (en) * 1986-05-12 1988-10-18 Diagnostic Products Corporation Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
GB8916859D0 (en) * 1989-07-24 1989-09-06 Dynal As Hapten linking
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell

Also Published As

Publication number Publication date
EP0652703A4 (fr) 1996-05-29
AU678179B2 (en) 1997-05-22
WO1994002016A1 (fr) 1994-02-03
EP0652703A1 (fr) 1995-05-17
AU4993793A (en) 1994-02-14

Similar Documents

Publication Publication Date Title
CA2141428A1 (fr) Methode d'immunoselection positive de cellules souches
JP4526749B2 (ja) 免疫ロゼットを用いる細胞分離法
CN109789092A (zh) 抗原呈递细胞模拟支架及其制备和使用方法
CN108474791A (zh) 培养细胞的方法及用于该方法的试剂盒和设备
CN104093314A (zh) 使用针对t/b细胞耗尽的特异性方案的用于稳定和长期植入的联合疗法
JPH0198477A (ja) ＩｇＧモノクローナル抗体−生産性ハイブリドマ
AU753975B2 (en) Methods of isolating and using CD7+CD34-Lin-hematopoietic cells
JPH0159871B2 (fr)
JPH01466A (ja) 急性伝染性単核症を検出する方法
US10881692B2 (en) Compositions for establishing mixed chimerism and methods of manufacture thereof
CA1175367A (fr) Lignee cellulaire hybride produisant un anticorps monoclonal contre un antigene humain des thymocytes, anticorps et methode d'utilisation
AU3062892A (en) Cd8 binding domain peptides
US6750326B2 (en) Method for separating cells using immunorosettes
JP2006122054A (ja) 骨髄始原細胞および／またはリンパ系始原細胞について富化される細胞集団、ならびに製造方法および使用方法
WO1995015340A1 (fr) Anticorps monoclonaux contre des antigenes exprimes par les cellules dendritiques humaines
Lokhorst et al. Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.
FR2864546A1 (fr) Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
EP0652943A1 (fr) Cellules hematopoietiques de facilitation et leurs utilisations
CN113347991A (zh) 用于消除和增强受试者骨髓中造血干细胞植入的组合物的组合
WO1996014853A1 (fr) Implantation intrathymique de cellules souches
JP2003534006A (ja) ヒト循環樹状細胞組成物および方法
JP3043629B2 (ja) 抗体１０３ｂ２
JP2023019830A (ja) ｉＰＳ細胞に対する免疫反応を評価する方法
Rabinowitz et al. In vitro activation leads to the binding of T-cell markers to the surface of B-lymphocytes
JPH07135969A (ja) ナチュラルキラー細胞の前駆細胞及びその分化増殖法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead